alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › neurodegenerative

neurodegenerative

6 studies tagged neurodegenerative, dated 2019-12-31 to 2025-05-01. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Biomarker discovery in Alzheimer's and neurodegenerative diseases using Nucleic Acid Linked Immuno-Sandwich Assay 2025-05-01
  2. Novel blood-based proteomic signatures across multiple neurodegenerative diseases 2025-03-01
  3. Neuropathological changes associated with aberrant cerebrospinal fluid p-tau181 and Aβ42 in Alzheimer's disease and other neurodegenerative diseases 2024-03-27

Studies

6 studies carry this tag.

Date range

2019 to 2025

Top journals

  • Alzheimer's & dementia : the journal of the Alzheimer's Association 3
  • Acta neuropathologica communications 1
  • Alzheimer's research & therapy 1
  • Journal of geriatric psychiatry and neurology 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Biomarker discovery in Alzheimer's and neurodegenerative diseases using Nucleic Acid Linked Immuno-Sandwich Assay

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2025-05-01 Biomarkers

    We underline the potential of next-generation biomarker identification tools to detect novel proteomic features that also incorporate established biomarkers.

  2. Novel blood-based proteomic signatures across multiple neurodegenerative diseases

    ✓ Peer-reviewed alzhub usefulness score 55 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2025-03-01 Biomarkers

    The sensitive NULISA multiplex approach supports differential diagnosis and target identification, with prognostically informative dementia-related biomarkers.

  3. Neuropathological changes associated with aberrant cerebrospinal fluid p-tau181 and Aβ42 in Alzheimer's disease and other neurodegenerative diseases

    ✓ Peer-reviewed alzhub usefulness score 55 out of 100. Acta neuropathologica communications 2024-03-27 Biomarkers

    Recent studies suggest that increased cerebrospinal fluid (CSF) phospho-tau is associated with brain amyloid pathology rather than the tau pathology.

  4. Association of plasma biomarkers with cognition, cognitive decline, and daily function across and within neurodegenerative diseases: Results from the Ontario Neurodegenerative Disease Research Initiative

    ✓ Peer-reviewed alzhub usefulness score 60 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2023-12-17 Biomarkers

    GFAP, NfL, and p-tau181 are valuable predictors of cognition and function across common neurodegenerative diseases, and may be useful in specialized clinics and clinical trials.

  5. Blood Biomarkers for the Diagnosis of Neurodegenerative Dementia: A Systematic Review

    ✓ Peer-reviewed alzhub usefulness score 72 out of 100. Journal of geriatric psychiatry and neurology 2022-11-24 Biomarkers

    Encouraging results were found for several biomarkers, alone or in combination.

  6. CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia

    ✓ Peer-reviewed alzhub usefulness score 51 out of 100. Alzheimer's research & therapy 2019-12-31 Biomarkers

    NDs share a CSF profile characterized by increased levels of CSF CHIT1, YKL-40, and GFAP, which likely reflects a common neuroinflammatory response to protein misfolding and aggregation.

All topic tags with their study counts